Chlamydia trachomatis is the world’s most frequently reported bacterial sexually transmitted infection. In women it is often asymptomatic yet can ascend from the cervix to the upper genital tract, ...

Eli Lilly announced Tuesday that it is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine Company, Inc., in deals ...

Eli Lilly enters three separate acquisitions totaling $3.83 billion in a push into vaccines and infectious diseases, signaling a strategic expansion into prevention-focused medicines. Eli Lilly ...

Eli Lilly and Co (NYSE:LLY) has announced agreements to acquire three vaccine developers, Curevo, LimmaTech Biologics AG, and ...

Eli Lilly is to acquire LimmaTech Biologics and Vaccine Company. Along with its acquisition of Curevo, the companies will ...

Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.

Pregnant patients tested for STIs in EDs are significantly less likely to receive empiric antibiotics than nonpregnant patients.

Bothell-based Curevo Vaccine, a privately held clinical-stage biotechnology company dedicated to developing vaccines with ...

On May 26, 2026, Eli Lilly announced that it had entered into agreements to acquire LimmaTech Biologics AG, Curevo Inc., and Vaccine Company, Inc.

LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by ...

Warming ocean waters are priming beaches and raw shellfish for Vibrio even as scientists are trying to stay one step ahead Bailey Magers and Sunil Kumar cut strange figures on Pensacola Beach. Bags of ...

Eli Lilly and Company announces three vaccine focused acquisitions to expand its infectious disease portfolio, targeting ...